Pulseless disease
Pulseless disease, also known as Takayasu's arteritis, is a rare type of vasculitis, a group of disorders that cause inflammation of the blood vessels. This disease primarily affects the aorta (the main blood vessel leaving the heart) and its branches, as well as the pulmonary arteries.
Symptoms[edit | edit source]
The symptoms of pulseless disease can vary greatly depending on which arteries are affected. Common symptoms include fatigue, weight loss, fever, night sweats, joint pain, and muscle pain. In some cases, the disease can lead to a weak or absent pulse in the arms or legs, hence the name "pulseless disease".
Causes[edit | edit source]
The exact cause of pulseless disease is unknown. However, it is believed to be an autoimmune disease, which means the body's immune system mistakenly attacks healthy tissue. Some researchers believe that a viral infection or other environmental factor may trigger the disease in people who are genetically predisposed to it.
Diagnosis[edit | edit source]
Diagnosis of pulseless disease can be challenging, as the symptoms can be similar to those of other conditions. Doctors typically use a combination of physical examination, medical history, and imaging tests such as angiography, MRI, or CT scan to diagnose the disease.
Treatment[edit | edit source]
Treatment for pulseless disease typically involves medications to reduce inflammation and suppress the immune system, such as corticosteroids and immunosuppressive drugs. In severe cases, surgery may be needed to repair or bypass affected arteries.
Prognosis[edit | edit source]
The prognosis for people with pulseless disease can vary widely. Some people may experience mild symptoms and require little treatment, while others may have severe disease that leads to serious complications such as stroke, heart attack, or heart failure.
See also[edit | edit source]
This vascular disease related article is a stub. You can help WikiMD by expanding it.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD